New Injectable Agents for the Treatment of Type 2 Diabetes Part 1-Injectable Insulins

摘要

The United States Food and Drug Administration has recently approved several new insulin products and new formulations of existing insulin products. These new products may provide advantages over older products, such as a lower risk of nocturnal hypoglycemia and ease of dosing; however, they are costly. The first of 2 articles in a series, this review will describe the potential advantages and disadvantages of these new insulin products. (C) 2018 Elsevier Inc. All rights reserved.